Literature DB >> 19628763

IL-4Ralpha responsiveness of non-CD4 T cells contributes to resistance in schistosoma mansoni infection in pan-T cell-specific IL-4Ralpha-deficient mice.

Benjamin Dewals1, Jennifer C Hoving, Mosiuoa Leeto, Reece G Marillier, Umeshree Govender, Antony J Cutler, William G C Horsnell, Frank Brombacher.   

Abstract

Interleukin (IL)-4 and IL-13 are T helper 2 cytokines whose biological functions are induced through a common IL-4 receptor alpha chain (IL-4Ralpha). CD4(+) T cell-specific IL-4Ralpha-mediated signaling drives susceptibility to Leishmania major infection, but is not essential to host survival following Schistosoma mansoni infection. Here we generated a novel mouse model lacking IL-4Ralpha expression specifically on all T cells (iLck(cre)Il4ra(-/lox)), which was compared with CD4(+) T cell-specific IL-4Ralpha-deficient mice (Lck(cre)Il4ra(-/lox)), to investigate the possible roles of IL-4Ralpha responsive non-CD4(+) T cells during either L. major or S. mansoni infection. Our results demonstrate a successful generation of transgene-bearing hemizygous iLck(cre)Il4ra(-/lox) BALB/c mice that have effective deletion of IL-4Ralpha on all T-cell populations. We show that iLck(cre)Il4ra(-/lox) mice infected with L. major developed a healing disease phenotype as previously observed in Lck(cre)Il4ra(-/lox) mice, demonstrating that absence of IL-4Ralpha-responsive non-CD4(+) in addition to CD4(+) T cells does not further affect transformation of BALB/c to a healer phenotype. In acute schistosomiasis, however, iLck(cre)Il4ra(-/lox) mice showed enhanced mortality compared with Il4ra(-/lox) and Lck(cre)Il4ra(-/lox) mice. iLck(cre)Il4ra(-/lox) mice died with similar kinetics to highly susceptible Il4ra(-/-) mice, despite controlling gut inflammation. In addition, iLck(cre)Il4ra(-/lox) mice presented increased liver granuloma sizes, as compared with Lck(cre)Il4ra(-/lox) mice, with similar eosinophils, fibrosis, and liver damage. In conclusion, IL-4Ralpha-responsive non-CD4(+) T cells prolong survival to acute schistosomiasis and contribute to the better control of hepatic granulomatous inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628763      PMCID: PMC2716945          DOI: 10.2353/ajpath.2009.090137

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

1.  Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice.

Authors:  Christoph Hölscher; Berenice Arendse; Anita Schwegmann; Elmarie Myburgh; Frank Brombacher
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 2.  Conditional gene targeting.

Authors:  K Rajewsky; H Gu; R Kühn; U A Betz; W Müller; J Roes; F Schwenk
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response.

Authors:  M H Kaplan; J R Whitfield; D L Boros; M J Grusby
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

4.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Authors:  Giovanna Gallina; Luigi Dolcetti; Paolo Serafini; Carmela De Santo; Ilaria Marigo; Mario P Colombo; Giuseppe Basso; Frank Brombacher; Ivan Borrello; Paola Zanovello; Silvio Bicciato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

Review 5.  The IL-4 receptor: signaling mechanisms and biologic functions.

Authors:  K Nelms; A D Keegan; J Zamorano; J J Ryan; W E Paul
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

6.  Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling.

Authors:  M Mohrs; B Ledermann; G Köhler; A Dorfmüller; A Gessner; F Brombacher
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

7.  Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; J M Ward; A W Cheever; W E Paul; A Sher
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

8.  TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis.

Authors:  Mosiuoa Leeto; De'Broski R Herbert; Reece Marillier; Anita Schwegmann; Lizette Fick; Frank Brombacher
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

9.  IL-4-deficient Balb/c mice resist infection with Leishmania major.

Authors:  M Kopf; F Brombacher; G Köhler; G Kienzle; K H Widmann; K Lefrang; C Humborg; B Ledermann; W Solbach
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.

Authors:  Magdalena Radwanska; Antony J Cutler; J Claire Hoving; Stefan Magez; Christoph Holscher; Andreas Bohms; Berenice Arendse; Richard Kirsch; Thomas Hunig; James Alexander; Paul Kaye; Frank Brombacher
Journal:  PLoS Pathog       Date:  2007-05-11       Impact factor: 6.823

View more
  17 in total

1.  IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases.

Authors:  Ramona Hurdayal; Hlumani H Ndlovu; Mélanie Revaz-Breton; Suraj P Parihar; Justin Komguep Nono; Melissa Govender; Frank Brombacher
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-15       Impact factor: 11.205

2.  Interleukin-4 Signaling Plays a Major Role in Urogenital Schistosomiasis-Associated Bladder Pathogenesis.

Authors:  Evaristus C Mbanefo; Chi-Ling Fu; Christina P Ho; Loc Le; Kenji Ishida; Olfat Hammam; Michael H Hsieh
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

3.  Pneumocystis infection alters the activation state of pulmonary macrophages.

Authors:  Jessica M Deckman; Cathryn J Kurkjian; Joseph P McGillis; Theodore J Cory; Susan E Birket; Linda M Schutzman; Brian S Murphy; Beth A Garvy; David J Feola
Journal:  Immunobiology       Date:  2016-10-05       Impact factor: 3.144

4.  IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness.

Authors:  Benjamin G Dewals; Reece G Marillier; Jennifer C Hoving; Mosiuoa Leeto; Anita Schwegmann; Frank Brombacher
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18

5.  Lung-resident CD4⁺ T cells are sufficient for IL-4Rα-dependent recall immunity to Nippostrongylus brasiliensis infection.

Authors:  S G Thawer; W G C Horsnell; M Darby; J C Hoving; B Dewals; A J Cutler; D Lang; F Brombacher
Journal:  Mucosal Immunol       Date:  2013-06-19       Impact factor: 7.313

6.  BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype.

Authors:  Karen J Bryson; Owain R Millington; Thabang Mokgethi; H Adrienne McGachy; Frank Brombacher; James Alexander
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

Review 7.  CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation.

Authors:  Thomas Hünig; Fred Lühder; Karin Elflein; Tea Gogishvili; Monika Fröhlich; Reto Guler; Antony Cutler; Frank Brombacher
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 3.402

Review 8.  Role of IL-4Rα during acute schistosomiasis in mice.

Authors:  H Ndlovu; F Brombacher
Journal:  Parasite Immunol       Date:  2014-09       Impact factor: 2.280

9.  Nippostrongylus-induced intestinal hypercontractility requires IL-4 receptor alpha-responsiveness by T cells in mice.

Authors:  Saskia Schmidt; J Claire Hoving; William G C Horsnell; Helen Mearns; Antony J Cutler; Tiroyaone M Brombacher; Frank Brombacher
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?

Authors:  James Alexander; Frank Brombacher
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.